WeDaita

Research Digest

AI-curated papers, approvals, clinical compounds, and disclosures from drug discovery's leading sources.

Scored for relevance by WeDaita AI · Updated weekly · Not editorial content

Computational and medicinal chemistry advances, approved drugs, and clinical pipeline entries across the full drug design lifecycle.

  • Literature — AI-driven molecular generation, virtual screening, ADMET prediction, and structure-based design from PubMed, arXiv, and Semantic Scholar
  • FDA Approval — Recently approved small-molecule drugs (NDA approvals) sourced from openFDA
  • Clinical Compound — Phase I–III candidates from ChEMBL — molecules in active clinical development not yet approved
  • Disclosure — New molecular series and compound profiles curated by Drug Hunter
  • Patent — Drug Hunter Patent Gazette roundups with expert annotations on assignees, targets, and key novelty claims
  • Industry News — Company announcements, funding rounds, and biotech media coverage
Industry News
brepocitinib
Oct 9, 2026 · Drug Hunter
Industry News
Targeting ARID1B by Converting Weak Binders Into Potent Degraders
Oct 8, 2026 · Drug Hunter
Industry News
New Approach Methodologies for Drug Safety Testing: Research to Clinical Development
Oct 7, 2026 · FierceBiotech · jkarimi